CV Outcomes Better With Cinacalcet, But Only in the ElderlyCV Outcomes Better With Cinacalcet, But Only in the Elderly

Although the EVOLVE study failed to meet its end point, a new subanalysis shows that cinacalcet improves time to death and cardiovascular (CV) end points in older patients. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news